Dublin, May 22, 2023 (GLOBE NEWSWIRE) -- The "Clinical Trials Scorecard for Clinical Trial Investigations in 2022" report has been added to ResearchAndMarkets.com's offering.
This report provides an overview of global clinical trials with a start date between January 1, 2022, and December 31, 2022.
Scope
The clinical trials data used for these analyses were extracted from the publisher's Clinical Trials Database. The data included clinical trials with a start date between January 1, 2022 and December 31, 2022, which were captured in the database as of February 14, 2023. The trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials
Reasons to Buy
- Trends of 2022 trial landscape
- Comparison to 2021 trial landscape
- Can view top therapy areas, indications, geographies and sponsors for 2022 trials
- Designated focus on completed and terminated trials for 2022
- Spotlight on COVID-19
Key Topics Covered:
- Executive Summary
- Introduction
- Global Clinical Trial Landscape in 2022
- Completed Trials in 2022
- Clinical Trial Terminations in 2022
- Spotlight on COVID-19 Clinical Trials for 2022
- Key Findings
For more information about this report visit https://www.researchandmarkets.com/r/20s0po
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
